Proposed $1.1-billion class-action suit targeting opioid drug makers filed in Ontario

The Globe and Mail, May 15, 2019

A Toronto law firm is suing more than two dozen pharmaceutical companies, accusing them of manufacturing an opioid epidemic that has killed thousands of Canadians and of reaping “obscene” profits through a “false and deceptive” marketing campaign.

Dr. Darryl Gebien [MSTH], the representative plaintiff, became addicted to opioids a decade ago when he took Percocet painkillers after a ligament injury in his thumb. He then switched to fentanyl, a powerful opioid that has been linked to numerous overdose deaths.

Proposed $1.1-billion class-action suit targeting opioid drug makers filed in Ontario